Publication: 2838

Publication: 2838

Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer?: A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Pancreas vol 43 (3) 343-349

Year:: 2014
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 546
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821 , U10 CA035267, U10 CA052352, CA-374-4, N01 CA035431, CA-52352, CA-63844, CA-35195, U10 CA180821, CA-7417, U10 CA035448, U10 CA035195, CA-35103, CA-25224, N01 CA063844, CA-35113, U10 CA035101, U10 CA035113, U10 CA035415, U10 CA063849, CA-35415, U10 CA035431, CA-35448, CA-35101, U10 CA025224, CA-35267, U10 CA063844, CA-63849, UL1 TR000371, U10 CA035103

Corr. Author:
Authors:: Katherine Van Loon Anne M. Espinoza David R. Fogelman Robert A. Wolff Milind M. Javle Renuka V. Iyer Vincent J. Picozzi Ludmila Katherine Martin Tanios Bekaii-Saab Margaret A. Tempero Nathan R. Foster George P. Kim Andrew H. Ko

Networks:

Study: NCCTG-N034A
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords:: pancreatic cancer, gemcitabine, clinical trial design, pooled analysis